Teva Pharmaceutical Industries has received approval from the U.S. Food and Drug Administration to market its Gemfibrozil 660mg tablets. Gemfibrozil is the generic equivalent of Lopid, a cholesterol-reducing agent from Warner Lambert. The annual U.S. market for the original versions of the drug is ...